Frequently asked questions for providers - October 4, 2021
Primary tabs
This archived document is maintained by the State Library of Oregon as part of the Oregon Documents
Depository Program. It is for informational purposes and may not be suitable for legal purposes.
| Title: | October 4, 2021. |
|
|---|
| Title: | Frequently asked questions for providers: monoclonal antibody (mAb) therapies for COVID-19. |
|
|---|---|---|
| Alternative Title: | [Monoclonal antibody treatment]. | |
| Name(s): |
Oregon Health Authority, issuing body. Oregon Health Authority Public Health Division, issuing body. |
|
| Type of Resource: | text | |
| Genre: |
government publication text FAQs. |
|
| Issuance: | monographic | |
| Date Issued: | [2021] | |
| Publisher: | Oregon Health Authority, | |
| Place of Publication: | Salem, OR : | |
| Physical Form: |
electronic resource remote computer online resource |
|
| Extent: | 1 online resource (volumes) | |
| Note(s): |
Title from agency website (viewed on August 16, 2021). "OHA 8313." Covers OCLC #1275786079, OCLC #1273556556, OCLC #1264085615. This archived document is maintained by the State Library of Oregon as part of the Oregon Documents Depository Program. It is for informational purposes and may not be suitable for legal purposes. Mode of access: Internet from the Oregon Government Publications Collection. Text in English. "OHA 3813." |
|
| Subject(s): |
n-us-or Monoclonal antibodies COVID-19 (Disease) -- Treatment -- Oregon |
|
| Held by: | Oregon State Library | |
| Restrictions on Access: |
http://rightsstatements.org/vocab/CNE/1.0/ http://rightsstatements.org/vocab/CNE/1.0/ |
|
| In Collections: |